TITLE:
A Study of Isoprinosine in Patients With Severe AIDS

CONDITION:
HIV Infections

INTERVENTION:
Inosine pranobex

SUMMARY:

      To evaluate the effect of Isoprinosine in patients diagnosed as having AIDS relative to:

      Laboratory (immunologic defects):

        -  Comparison of total helper and suppressor T-cell numbers among the groups.

        -  Comparison of changes in natural killer cell activity.

        -  Comparison of other laboratory findings among the groups.

      Clinical changes:

        -  Comparison of the frequency of opportunistic infections among the groups.

        -  Comparison of the frequency of the development of AIDS-related malignancies.

        -  Comparison of other clinical manifestations relative to severity and time of onset.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Exclusion Criteria

        Co-existing Condition:

        Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and
        severe gastric ulcer are excluded.

        Concurrent Medication:

        Excluded:

          -  Steroids.

          -  Cytotoxic immunosuppressive agents.

          -  Radiotherapy.

        The following are excluded:

          -  Critically ill patients.

          -  Patients receiving steroids, cytotoxic immunosuppressive agents, radiotherapy.

          -  Patients who have received any other immunotherapy.

          -  Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction,
             and severe gastric ulcer.

        Prior Medication:

        Excluded:

          -  Any other immunotherapy.

        Patients with severe AIDS and specified laboratory immunologic defects.
      
